Preventing mother-to-child HIV transmission - The first year of Thailand's national program

被引:33
作者
Amornwichet, P
Teeraratkul, A
Simonds, RJ
Naiwatanakul, T
Chantharojwong, N
Culnane, M
Tappero, JW
Kanshana, S
机构
[1] Minist Publ Hlth, Dept Hlth, Nonthaburi 11000, Thailand
[2] Thailand Minist Publ Hlth US Ctr Dis Control & Pr, Nonthaburi, Thailand
[3] Ctr Dis Control & Prevent, Global AIDS Program, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 288卷 / 02期
关键词
D O I
10.1001/jama.288.2.245
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Each year in Thailand, about 10000 children are born at risk for mother-to-child human immunodeficiency virus (HIV) transmission. In 2000, Thailand implemented a national program to prevent mother-to-child HIV transmission. Objective To describe the results of implementation of the program. Design Monthly collection of summary data from hospitals. Setting Public health hospitals (n=822) in all 12 regions of Thailand, representing .75 provinces, excluding Bangkok. Participants Women giving birth from October 2000 through September 2001, including HIV-seropositive women and their neonates. Main Outcome Measures Percentages of women giving birth who were tested for HIV, HIV-seropositive women giving birth who received antenatal prophylactic antiretroviral drugs, and HIV-exposed neonates who received prophylactic antiretroviral drugs and infant formula. Results Among 573 655 women (range, 27344-77806 by region) giving birth, 554 912 (96.7%) received antenatal care (range, 91.9%-98.8% by region). Of 554912 women giving birth who had antenatal care, 517488 (93.3%) were tested for HIV (range, 87.7%-99.4% by region) before giving birth; of 18743 women giving birth who did not have antenatal care, 13314 (71.0%) were tested for HIV (range, 21.7%-92.9% by region). Of 6646 HIV-seropositive women giving birth, 4659 (70.1%) received prophylactic antiretroviral drugs before delivery (range, 55.3%-81.2% by region). Of 6475 neonates of HIV-seropositive women, 5741 (88.7%) received prophylactic antireiroviral, drugs (range, 67.4%-96.9% by region) and 5386 (83.2%) received infant formula (range, 65.3%-100% by-region). Conclusions Major program components of Thailand's national program for preventing mother-to-child HIV transmission were implemented. Thailand's experience may encourage other developing countries to implement or expand similar national programs.
引用
收藏
页码:245 / 248
页数:4
相关论文
共 16 条
[1]  
*CDCP, 2001, MMWR-MORBID MORTAL W, V50, P599
[2]  
Dean AG, 1995, EPI INFO VERSION 6
[3]   Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVMET 012 randomised trial [J].
Guay, LA ;
Musoke, P ;
Fleming, T ;
Bagenda, D ;
Allen, M ;
Nakabiito, C ;
Sherman, J ;
Bakaki, P ;
Ducar, C ;
Deseyve, M ;
Emel, L ;
Mirochnick, M ;
Fowler, MG ;
Mofenson, L ;
Miotti, P ;
Dransfield, K ;
Bray, D ;
Mmiro, F ;
Jackson, JB .
LANCET, 1999, 354 (9181) :795-802
[4]   Implementing short-course zidovudine to reduce mother-infant HIV transmission in a large pilot program in Thailand [J].
Kanshana, S ;
Thewanda, D ;
Teeraratkul, A ;
Limpakarnjanarat, K ;
Amornwichet, P ;
Kullerk, N ;
Akksilp, S ;
Sereesittipitak, V ;
Mastro, TD ;
Simonds, RJ .
AIDS, 2000, 14 (11) :1617-1623
[5]   National program for preventing mother-child HIV transmission in Thailand: successful implementation and lessons learned [J].
Kanshana, S ;
Simonds, RJ .
AIDS, 2002, 16 (07) :953-959
[6]   A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1 [J].
Lallemant, M ;
Jourdain, G ;
Le Coeur, S ;
Kim, S ;
Koetsawang, S ;
Comeau, AM ;
Phoolcharoen, W ;
Essex, M ;
McIntosh, K ;
Vithayasai, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (14) :982-991
[7]  
*MIN PUBL HLTH THA, 2000, NAT GUID CLIN MAN HI
[8]  
NOLAN M, 2001, 3 C GLOB STRAT PREV
[9]  
ROONGPISUTHIPON.A, 2001, 3 C GLOB STRAT PREV
[10]   Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial [J].
Shaffer, N ;
Chuachoowong, R ;
Mock, PA ;
Bhadrakom, C ;
Siriwasin, W ;
Young, NL ;
Chotpitayasunondh, T ;
Chearskul, S ;
Roongpisuthipong, A ;
Chinayon, P ;
Karon, J ;
Mastro, TD ;
Simonds, RJ .
LANCET, 1999, 353 (9155) :773-780